Table 5.

Previous studies of hepatitis C virus (HCV) in patients with rheumatic diseases.

Study, Ref.CountryInclusion PeriodDisease, no.HCV Seroprevalence, %Prevalence HCV/General Population, %Patient Age, mean, yrsFemale/Male, %
ESPOIR cohortFrance2003–2005Recent-onset polyarthritis, 8130.86148.0776.7:23.3
Maillefert, 4, 12France1999–2001RA, 3090.65154.175:25
Rivera, 13Spain1995–1996RA, 3037.60.9558.377:23
Hsu, 14USA1988–1994Probable RA, 19611.37151:49
Barbosa, 15Brazil2000Inflammatory rheumatic diseases, 3671.90.9 to 238.385:15